Form 4: LeMaitre Vascular Director Reports Dividend Accruals

Director John A. Roush reported the accrual of dividend equivalent rights on existing equity awards.

Summary

• Director John A. Roush received additional dividend equivalent rights totaling 4.0705 units.
• These rights accrued on previously granted restricted stock units and performance share units.
• Each dividend equivalent right represents the economic equivalent of one share of LeMaitre Vascular common stock.
• The accruals occurred on June 4, 2026, following dividend distributions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing with no impact on company strategy or financial outlook.

Positives

• Reflects ongoing dividend payments to equity holders, indicating consistent capital return policy.

Negatives

• None identified; this is a routine administrative disclosure of dividend accruals.

Risks

• None; this filing relates to standard compensation and dividend tracking.

Future Outlook

No forward-looking guidance provided; this is a retrospective disclosure of dividend accruals.

Industry Context

StockSavvy.ai notes that routine dividend equivalent accruals for directors are standard practice in the medical device sector, signaling stable corporate governance and alignment with shareholder interests.

Comparison to Industry Standards

• Consistent with standard executive compensation practices for mid-cap medical device companies.
• Dividend equivalent rights are a common mechanism to prevent dilution of director equity stakes during dividend payouts.

Stakeholder Impact

• Minimal impact; confirms director alignment with dividend-receiving shareholders.

Next Steps

• Future vesting of underlying restricted stock units and performance share units according to original grant schedules.

Key Dates

Keywords

LeMaitre Vascular, LMAT, Director, Dividend Equivalent Rights, Insider Ownership, SEC Form 4